Overview
SeromYx Systems harnesses cutting-edge technology, leveraging high-throughput cell and bead-based assays combined with advanced machine learning to understand the complex functions of antibodies in the immune system. Our Systems Serology platform enables pharmaceutical and biotechnology companies to design vaccines with unmatched precision by profiling the critical interactions between antibodies and innate immune cells. We support vaccine development by identifying correlates of protection and uncovering the key antibody functions that drive safety and efficacy in immune responses.
From preclinical design through clinical trials, we provide comprehensive analysis and robust insights to ensure effective vaccine formulations that target infectious diseases. We help clients optimize vaccine candidates from discovery through regulatory approval in a GCLP-certified facility. SeromYx is committed to revolutionizing immunology, driving the development of vaccines that save lives and improve global health.